VANGUARD GROUP INC

Position in OTLK — Outlook Therapeutics, Inc.

CIK 102909 Valley Forge, PA

Position in OTLK

as of Dec 31, 2025 · filed Jan 29, 2026 Compact

Position Value

$2,314,962

+$891,779 QoQ

Shares Held

1,465,167

+9.1% QoQ

Ownership

1.21%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

8 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 12.048387658198688.ToString("F0")% None 87.95161234180131.ToString("F0")%

Healthcare · as of Dec 31, 2025

VANGUARD GROUP INC holds $65,710,756,184 across 450 Biotechnology names. OTLK ranks #310 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	24,105,823	$10,928,615,912
2	REGN	Regeneron Pharmaceuticals, Inc.	9,075,153	$7,004,838,343
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,553,932	$5,389,721,058
4	INSM	INSMED Inc	21,076,344	$3,668,126,907
5	INCY	Incyte Corp	19,911,434	$1,966,652,333
6	RVMD	Revolution Medicines, Inc.	16,719,886	$1,331,738,919
7	IONS	Ionis Pharmaceuticals Inc	16,440,459	$1,300,604,709
8	BBIO	BridgeBio Pharma, Inc.	16,862,691	$1,289,827,232

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2025-12-31	$2,314,962	1,465,167	+9.1%	Shares	Sole	2026-01-29
2025-09-30	$1,423,183	1,342,627	+7.3%	Shares	Defined	2025-11-07
2025-06-30	$2,002,556	1,251,598	+49.5%	Shares	Sole	2025-08-11
2025-03-31	$1,021,635	837,407	-1.8%	Shares	Defined	2025-05-09
2024-12-31	$1,611,299	852,540	-0.4%	Shares	Defined	2025-02-11
2024-09-30	$4,570,376	855,876	+56.2%	Shares	Defined	2024-11-13
2024-06-30	$4,042,563	547,773	+60.5%	Shares	Defined	2024-08-13
2024-03-31	$4,075,120	341,300	—	Shares	Defined	2024-05-10
No filing history on record for this holder in this stock.